Master Investor Conference Attendance

Ananda Pharma PLC

12 March 2025

 

 12 March 2025

ANANDA PHARMA PLC

("Ananda" or the "Company")

Ananda to present at Master Investor Show in London

Ananda Pharma plc (AQSE: ANA), a UK-based biopharmaceutical company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, is pleased to announce that its leadership team will be presenting the Ananda Pharma opportunity at the Master Investor Show in London at The Business Design Centre, 52 Upper Street, London N1 0QH, on Saturday, 29^th March. Ananda will be present all day at booth M:35.

Jeremy Sturgess-Smith, Finance Director will be presenting on the Showcase stage at 10:25, the Company will also be exhibiting at Booth M:35 throughout the day and Melissa Sturgess, CEO will also be attending the event all day.

Melissa Sturgess, CEO, commented: "We are very much looking forward to participating in Master Investor again this year. It is a great opportunity to speak to existing and potential new shareholders about our drive to bring cannabis based, regulatory approved medicines to the market. We invite everyone to come and say hello at our Booth, number M:35."

To register for the Master Investor Show, please use the following link: https://masterinvestorshow-2025.reg.buzz/?exhibitor-inviter=848eac18-dfd9-11ef-99be-000000000000

About Ananda Pharma

Ananda Pharma (AQSE: ANA) is a UK-based biopharmaceutical company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, including epilepsy (trials funded by NHS England and NIHR), endometriosis (funded by NHS Scotland) and chemotherapy pain (funded by NIHR).  The Company is led by successful entrepreneurs and is working with a team of world-class scientists, including globally respected Key Opinion Leaders at the University of Edinburgh, Great Ormond Street Hospital for Children and University College London.

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

·              Investor Hub: https://investors.anandapharma.co.uk/s/ea8f93

·              Instagram: https://www.instagram.com/anandapharmaplc/

·              LinkedIn:  https://www.linkedin.com/company/anandapharma

·              X: https://twitter.com/AnandaPlc

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

For more information please contact:

ANANDA PHARMA PLC Chief Executive Officer Melissa Sturgess Finance Director Jeremy Sturgess-Smith	[phone] [e-mail]
SP ANGEL CORPORATE FINANCE LLP Corporate Finance Richard Morrison Josh Ray	[phone]
Corporate Broking Abigail Wayne Rob Rees
YELLOW JERSEY PR Sarah Macleod Charles Goodwin Zara McKinlay	[phone] [e-mail]

https://investors.anandapharma.co.uk/link/mep3Xy

 

END